Sutro Biopharma, Inc.: Form 8-K, filed May 15, 2019
Filed with the SEC on May 15, 2019 and accepted by EDGAR at May 15, 2019, 07:00 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001564590-19-019255. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.